Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

MS therapeutics from Lilly

Aug. 14, 1997

NIH report on marijuana therapy released

Aug. 14, 1997

SIBIA Neurosciences and Lilly near completion of VGCC research collaboration

Aug. 14, 1997

Myotrophin NDA review period extended by FDA

Aug. 14, 1997

Tuberous sclerosis complex gene identified

Aug. 14, 1997

YM-872 shows potential for stroke in animal models

Aug. 13, 1997

Antiischemic activity of calmodulin antagonist reported

Aug. 13, 1997

NR2B-selective NMDA antagonist for occlusive stroke

Aug. 13, 1997

Bradykinin antagonist shows potential in stroke and ischemic disorders

Aug. 13, 1997

YM90K efficacy shown in rat model of cerebral ischemia

Aug. 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Science
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Asia
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...